Search Medicilon

Preclinical CRO

China’s First mRNA-Based In Vivo CAR-T Candidate! Medicilon Supports Regenelead RGL-208 IND Approval

Preclinical CRO

Medicilon and China Pharmaceutical University Forge Industry-University Research Collaboration on Novel Conjugate Therapeutics to Empower New Drug Innovation

Preclinical CRO

7th Anniversary Q&A 7: Seven Years Listed, Honors Without Number: Why Does Medicilon Keep the Trust of the Industry and Its Clients?

Contact Medicilon

Name(Required)
Address(Required)